Predictive value of serologic markers of degree of histologic damage in acute uncomplicated colonic diverticulitis

Journal of Clinical Gastroenterology

Volumn 44, Issue 10, 2010, Pages 702-706

  Tursi, Antonio ^a   Elisei, Walter ^b   Brandimarte, Giovanni ^c   Giorgetti, Gian Marco ^d   Aiello, Fabio ^e  

^a ASL BAT   (Italy)

^b ASL RMH   (Italy)

^c Cristo Re Hospital   (Italy)

^d S EUGENIO HOSPITAL   (Italy)

^e UNIVERSITY OF PALERMO   (Italy)

Author keywords

acute uncomplicated diverticulitis; predictive value; serologic markers

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; OROSOMUCOID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON DIVERTICULOSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GASTROINTESTINAL ENDOSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; LEUKOCYTE; LYMPHOCYTIC INFILTRATION; MALE; NEUTROPHIL; PRIORITY JOURNAL; PROGNOSIS; SEROLOGY;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; COLON; COLONOSCOPY; DIVERTICULITIS, COLONIC; FEMALE; FIBRINOGEN; HUMANS; INFLAMMATION MEDIATORS; ITALY; LEUKOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHIL INFILTRATION; OROSOMUCOID; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77958464310     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181dad979     Document Type: Article

References (35)

1. Comparato G, Pilotto A, Franze A, et al. Diverticular disease in the elderly. Dig Dis. 2007;25:151-159.
2. Jun S, Stollman N. Epidemiology of diverticular disease. Best Pract Res Clin Gastroenterol. 2002;16:529-542.
3. Bogardus ST Jr. What do we know about diverticular disease? A brief overview. J Clin Gastroenterol. 2006;40:S108-S111.
4. Hjern F, Johansson C, Mellgren A, et al. Diverticular disease and migration\the influence of acculturation to a Western lifestyle on diverticular disease. Aliment Pharmacol Ther. 2006; 23:797-805.
5. Parks TG. Natural history of diverticular disease of the colon. Clin Gastroenterol. 1975;4:53-69.
6. Aydin HN, Remzi FH. Diverticulitis: when and how to operate? Dig Liver Dis. 2004;36:435-445.
7. Boles RS Jr, Jordan SM. The clinical significance of diverticulosis. Gastroenterology. 1958;35:579-582.
8. Rafferty J, Shellito P, Hyman NH, et al. Practice parameters for sigmoid diverticulitis. Dis Colon Rectum. 2006;49:939-944.
9. Salzman H, Lillie D. Diverticular disease: diagnosis and treatment. Am Fam Physician. 2005;72:1229-1234.
10. Kohler L, Sauerland S, Neugebauer E. Diagnosis and treatment of diverticular disease: results of a consensus development conference. The Scientific Committee of the European Association for Endoscopic Surgery. Surg Endosc. 1999;13:430-436.
11. Floch MH, White JA. Management of diverticular disease is changing. World J Gastroenterol. 2006;12:3225-3228.
12. Tursi A. New physiopathological and therapeutic approaches to diverticular disease of the colon. Expert Opin Pharmacother. 2007;8:299-307.
13. Floch MH. A hypothesis: is diverticulitis a type of inflammatory bowel disease? J Clin Gastroenterol. 2006;40:S121-S125.
14. Morini S, Hassan C, Zullo A, et al. Epithelial cell proliferation of the colonic mucosa in diverticular disease: a case-control study. Aliment Pharmacol Ther. 2005;21:1385-1390.
15. Tursi A, Brandimarte G, Elisei W, et al. Epithelial cell proliferation of the colonic mucosa in different degrees of colonic diverticular disease. J Clin Gastroenterol. 2006;40:306-311.
16. Tursi A, Brandimarte G, Elisei W, et al. Assessment and grading of mucosal inflammation in colonic diverticular disease. J Clin Gastroenterol. 2008;42:699-703.
17. Tursi A, Brandimarte G, Giorgetti G, et al. The clinical picture of uncomplicated versus complicated diverticulitis of the colon. Dig Dis Sci. 2008;53:2474-2479.
18. Lawrimore T, Rhea JT. Computed tomography evaluation of diverticulitis. J Intensive Care Med. 2004;19:194-204.
19. Lahat A, Yanai H, Menachem Y, et al. The feasibility and risk of early colonoscopy in acute diverticulitis: a prospective controlled study. Endoscopy. 2007;39:521-524.
20. Brandimarte G, Elisei W, Giorgetti GM, et al. Can endoscopy differentiate between ulcerative colitis with diverticulosis, segmental colitis associated with diverticulosis ("SCAD"), and acute uncomplicated colonic diverticulitis? Digest Liver Dis. 2009;41(suppl. 1):S148.
21. Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut. 2006;55:426-431.
22. Solem CA, Loftus EV Jr, Tremaine WJ, et al. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:707-712.
23. Osada T, Ohkusa T, Okayasu I, et al. Correlations among total colonoscopic findings, clinical symptoms, and laboratory markers in ulcerative colitis. J Gastroenterol Hepatol. 2008; 23(suppl. 2):S262-S267.
24. Henriksen M, Jahnsen J, Lygren I, et al; IBSEN Study Group. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study. Gut. 2008;57:1518-1523.
25. Gisbert JP, Gonzalez-Lama Y, Mate J. Role of biological markers in inflammatory bowel disease. Gastroenterol Hepatol. 2007;30:117-129.
26. Barnes BH, Borowitz SM, Saulsbury FT, et al. Discordant erythrocyte sedimentation rate and C-reactive protein in children with inflammatory bowel disease taking azathioprine or 6-mercaptopurine. J Pediatr Gastroenterol Nutr. 2004;38: 509-512.
27. Linskens RK, van Bodegraven AA, Schoorl M, et al. Predictive value of inflammatory and coagulation parameters in the course of severe ulcerative colitis. Dig Dis Sci. 2001;46: 644-648
28. Grzymisawski M, Derc K, Sobieska M, et al. Microhetero-geneity of acute phase proteins in patients with ulcerative colitis. World J Gastroenterol. 2006;12:5191-5195.
29. Lok KH, Ng CH, Hung HG, et al. Correlation of serum biomarkers with clinical severity and mucosal inflammation in Chinese ulcerative colitis patients. J Dig Dis. 2008;9:219-224.
30. Shen J, Ran ZH, Zhang Y, et al. Biomarkers of altered coagulation and fibrinolysis as measures of disease activity in active inflammatory bowel disease: a gender-stratified, cohort analysis. Thromb Res. 2009;123:604-611.
31. Tomei E, Diacinti D, Marini M, et al. Computed tomography of bowel wall in patients with Crohn's disease: relationship of inflammatory activity to biological indices. Ital J Gastroenterol. 1996;28:487-492.
32. Lee SS, Ha HK, Yang SK et al. CT of prominent pericolic or perienteric vasculature in patients with Crohn's disease: correlation with clinical disease activity and findings on barium studies. Am J Roentgenol. 2002;179:1029-1036.
33. Tursi A, Papagrigoriadis S. Review article: the current and evolving treatment of colonic diverticular disease. Aliment Pharmacol Ther. 2009;30:532-546.
34. Tursi A. Diverticular disease: what is the best long-term treatment? Nat Rev Gastroenterol Hepatol. 2010;7:77-78.
35. Tursi A, Brandimarte G, Elisei W, et al. Faecal calprotectin in colonic diverticular disease: a case-control study. Int J Colo-rectal Dis. 2009;24:49-55.